tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RPRX Stock Latest News

Royalty Pharma’s Internalization Strategy: Navigating Risks and Uncertainties Ahead of 2025 Transition
Company AnnouncementsRoyalty Pharma’s Internalization Strategy: Navigating Risks and Uncertainties Ahead of 2025 Transition
8d ago
RPRX
Royalty Pharma announces R&D funding collaboration with Biogen
PremiumThe Fly
Royalty Pharma announces R&D funding collaboration with Biogen
9d ago
BIIB
RPRX
Royalty Pharma PLC Reports Strong 2024 Financial Results
PremiumCompany Announcements
Royalty Pharma PLC Reports Strong 2024 Financial Results
9d ago
RPRX
Royalty Pharma’s Optimistic Earnings Call Highlights Growth
PremiumCompany Announcements
Royalty Pharma’s Optimistic Earnings Call Highlights Growth
9d ago
RPRX
Royalty Pharma reports Q4 portfolio receipts of $742M
PremiumThe Fly
Royalty Pharma reports Q4 portfolio receipts of $742M
10d ago
RPRX
Royalty Pharma sees FY25 portfolio receipts $2.9B-$3.05B
PremiumThe FlyRoyalty Pharma sees FY25 portfolio receipts $2.9B-$3.05B
10d ago
RPRX
Royalty Pharma PLC (RPRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Royalty Pharma PLC (RPRX) Q4 Earnings Cheat Sheet
12d ago
RPRX
Royalty Pharma announces sale of MorphoSys development funding bonds
Premium
The Fly
Royalty Pharma announces sale of MorphoSys development funding bonds
23d ago
RPRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
DTIL
IGMS
Royalty Pharma Announces 2024 Achievements and Strategic Plans
PremiumCompany Announcements
Royalty Pharma Announces 2024 Achievements and Strategic Plans
1M ago
8K
RPRX
Royalty Pharma’s Strategic Moves and Share Buyback Plan
PremiumCompany Announcements
Royalty Pharma’s Strategic Moves and Share Buyback Plan
1M ago
8K
RPRX
Unusually active option classes on open January 10th
PremiumThe Fly
Unusually active option classes on open January 10th
1M ago
CMA
PBI
Royalty Pharma announces two steps to increase shareholder value
PremiumThe FlyRoyalty Pharma announces two steps to increase shareholder value
1M ago
RPRX
Royalty Pharma sees FY24 revenue $2.8B, consensus $2.65B
Premium
The Fly
Royalty Pharma sees FY24 revenue $2.8B, consensus $2.65B
1M ago
RPRX
Royalty Pharma increases quarterly dividend 5% to 22c per share
Premium
The Fly
Royalty Pharma increases quarterly dividend 5% to 22c per share
1M ago
RPRX
Royalty Pharma increases quarterly dividend 5% to 22c per Class A share
PremiumThe Fly
Royalty Pharma increases quarterly dividend 5% to 22c per Class A share
1M ago
RPRX
Royalty Pharma price target raised to $39 from $38 at BofA
PremiumThe Fly
Royalty Pharma price target raised to $39 from $38 at BofA
3M ago
RPRX
Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024
PremiumMarket News
Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024
3M ago
AJX
BRY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
RDY
TAK
Geron announces $375M in synthetic royalty, debt financings with Royalty Pharma
PremiumThe FlyGeron announces $375M in synthetic royalty, debt financings with Royalty Pharma
4M ago
GERN
RPRX
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M
Premium
The Fly
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M
4M ago
GERN
RPRX
Royalty Pharma Reports Strong Q3 2024 Results
Premium
Company Announcements
Royalty Pharma Reports Strong Q3 2024 Results
4M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >